Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome. Myllymaki M, Redd R, Reilly CR, Saber W, et al. Blood 2020;136:3070-3081.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Myllymaki M, Redd R, Reilly CR, Saber W, et al. Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome. Blood 2020;136:3070-3081.
PMID: 33367544